The trademark application BYOOVIZ was filed by Biogen International GmbH, a corporation established under the laws of the Swiss Confederation (the "Applicant"). The application was published for oppositions on July 28, 2020, and it was registered by office on November 4, 2020 without any oppositions.
The application was filed in English (French was selected as the second language).
A total of undefined cancellation proceedings were initiated against the trademark registration in 2020.The first Cancellation was filed by Novartis AG (represented by Nordemann Czychowski & Partner Rechtsanwältinnen und Rechtsanwälte mbB) on November 30, 2023 and Final decision – Request rejected on formalities.
Deletion of the representative of the trademark registration was recorded on January 6, 2021. Appointment and Replacement of representative of the trademark registration was recorded on August 17, 2021. Application for revocation or for a declaration of invalidity of the trademark registration was recorded on September 12, 2021. Appointment and Replacement of representative of the trademark registration was recorded on September 30, 2021. Appointment and Replacement of representative of the trademark registration was recorded on October 17, 2021. Partial Surrender of the trademark registration was recorded on September 7, 2022. Decisions on applications for revocation or for a declaration of invalidity of the trademark registration was recorded on December 4, 2023. Appointment and Replacement of representative of the trademark registration was recorded on June 6, 2024. A transfer of the trademark registration was recorded on June 13, 2024.
The Appeal with reference B R1340/2023-2 was Other according to Article 109(4) EUTMR with decision issued on November 28, 2023 by the EUIPO. The Cancellation with reference B 000051207 was Cancellation rejected according to Article 60(1)(a) EUTMR with decision issued on April 26, 2023 by the EUIPO.